Roivant Sciences Ltd annual net income for fiscal TTM was -$266 million, an increase of 11.3% from -$300 million in fiscal 2026. All figures are reported results from public filings — no estimates or projections.
| Net Income (annual) | TTM → 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | ($266M) | ($300M) | ($172M) | $4.3B | ($1.0B) | ($845M) | ($809M) | $1.2B | ($1.0B) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Net Income (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | ($190M) | $303M | ($266M) | ($114M) | ($223M) | ($206M) | $169M | ($230M) | ($230M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More ROIV metrics: Revenue · Gross Profit · Operating Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All ROIV financial statements → Interactive ROIV charts →
About TickerBase · Data methodology & sources · Privacy · Terms